RX Biosyent Inc
- 8.510
- -0.140-1.62%
Biosyent Inc News
BioSyent to Attend Planet MicroCap Showcase
MISSISSAUGA, Ontario, April 23, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevad
BioSyent Announces Extension of RepaGyn and Proktis-M Agreement
MISSISSAUGA, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. ("Bi
BioSyent Inc. Spotlights at Investor Conference
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co. Healthc
FeraMAX Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year
MISSISSAUGA, Ontario, April 03, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that FeraMAX is the #1 recommended iron supplement brand in Canada, based
BioSyent to Present at LD Micro New York Investor Conference
MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent" or the "Company", TSX Venture: RX) announces that Mr. René Goehrum, President and CEO of BioSyent, will be present
BioSyent Announces Grant of Restricted Share Units
MISSISSAUGA, Ontario, March 27, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent" or the "Company", TSX Venture: RX) announces that its Board of Directors has approved a grant of 66,020 Restricted
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023
MISSISSAUGA, Ontario, March 13, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended Decembe
BioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024
MISSISSAUGA, Ontario, March 06, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) will be reporting its financial results for the three months and full year ended D
BioSyent Named to 2024 TSX Venture 50
MISSISSAUGA, Ontario, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that it has been named to the 2024 TSX Venture 50 list as on
BioSyent Declares First Quarter 2024 Dividend
MISSISSAUGA, Ontario, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividen
BioSyent Announces Renewal of Normal Course Issuer Bid
MISSISSAUGA, Ontario , Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that the TSX Venture Exchange ("TSX-V") has accepted the Co
BioSyent Announces the Availability of Gelclair in Canada
New Treatment for Painful Mouth Sores Due to Cancer TherapyMISSISSAUGA, Ontario, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce t
BIOSYENT INC To Go Ex-Dividend On November 29th, 2023 With 0.02908 USD Dividend Per Share
November 17th - $BIOSYENT INC(BIOYF.US)$ is trading ex-dividend on November 29th, 2023. Shareholders of record on November 30th, 2023 will receive 0.02908 USD dividend per share on December 15th,
BioSyent Releases Q3 and YTD 2023 Financial Results
MISSISSAUGA, Ontario, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended Septemb
BioSyent Declares Fourth Quarter 2023 Dividend
BioSyent Schedules Q3 and YTD 2023 Earnings Release for November 16, 2023
MISSISSAUGA, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) will be reporting its financial results for the three and nine months ended Septemb
BioSyent Launches "Menopauseinformation.ca" on World Menopause Day
MISSISSAUGA, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce the launch of menopauseinformation.ca, a comprehensive online platform desi
Why You Might Be Interested In BioSyent Inc. (CVE:RX) For Its Upcoming Dividend
Estimating The Intrinsic Value Of BioSyent Inc. (CVE:RX)
